EARNING RECAP

Alphabet Class A

#GOOGL 2019 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q2 $14.21 est. $11.30 $38.94B est. $38.15B +9.62% ($1245.22 closing price) $1268.39 $1228 Q2 properties revenues $27.34B vs: $23.26B a year ago; CEO says" incredibly excited by momentum across businesses
Q1 ex-fine $11.90 est. $10.56 $36.34B e st. $37.34B -7.50% ($1198.96 closing price) $1200.98 $1183 Q1 properties revenue $25.68B vs. $22B last year; Q1 other Bets revenue $170M vs. $150M a year ago
#GOOGL 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $12.77 est. $10.86 $39.28B est. $38.98B +.92% ($1151.87 closing price) $1152.77 $1123.60 CPC on Google properties down 29% YoY, down 9% QoQ; Q4 properties revenue $27.02b vs. $22.42B last yr
Q3 $13.06 est. $10.40 $33.74B est. $34.05B -1.80% ( $1083.75 closing) $1117 $1042.23 says Q3 CPC on Google properties down 28% vs: last year; Paid clicks on Google properties up 62% vs: last year; says Q3 traffic acquisitions cost $6.58B vs. $5.5B last year.
Q2 ex fines $11.75 est. $9.59 $32.66B est. $32.19B +3.89% ($1258.15 closing) $1275 $1244.14 Q2 paid clicks in Google properties up 58%, CPC down 22%, Q2 revenue up 26 YoY
Q1 $13.33 est. $9.31 $31.15B est. $30.31B -4.77% ($1022 closing) $1064.49 $1012.85 Paid clicks in google properties up 59% YoY, cost per impression up 18%
#GOOGL 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $9.70 est. $9.98 $32.32B est. $31.87B. : -5.28% ($1119.20 closing) $1131.30 $1111.17 Q4 aggregate paid clicks up 43% vs. last year; CPC down 14& vs. last year; authorize share repurchase up to $8.6B on Class C shares
Q3 $9.57 vs. $8.33 $27.8B vs. $27.2B +4.26% ($1033.67 closing) $1063.62 $1026.85 Record high* Revenue up 24% YoY* YoY CPC -18%; PC +47%;
Q2 $5.01 VS $4.46 Est. $26.01B vs $25.64B -2.93% ($969.03 closing) $976.73 $963.80 Pop and drops reaction. -2.94% or -29.31 points to $969.00
Q1 $7.73 vs $7.40 est $24.75B vs $24.22B +3.71% ($924.52 closing) $935.90 $923.22 Rallies +4.3% @ $929.70 AH. Our excellent results represent a terrific start to 2017, with revenues up 22% versus the first quarter of 2016 and 24% on a constant currency basis

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.